Cover Image
市場調查報告書

全球動物醫療的抗球蟲藥市場:全球的趨勢與預測

Global Anticoccidial Drugs Market in Animal Health - Trends and Forecasts (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 319306
出版日期 內容資訊 英文 193 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球動物醫療的抗球蟲藥市場:全球的趨勢與預測 Global Anticoccidial Drugs Market in Animal Health - Trends and Forecasts (2017 - 2022)
出版日期: 2017年01月24日 內容資訊: 英文 193 Pages
簡介

由於全世界人口增加和平均每個人的肉消費量增加等,全球動物醫療的抗球蟲藥市場預計至2020年達243億3,000萬美元。預計亞太地區2020年為止的市場收益的最大佔有率。

本報告提供全球動物醫療的抗球蟲藥市場相關調查、市場趨勢、抗球蟲藥概要、各地區、動物的市場、打入市場的主要企業的競爭環境與簡介彙整。

第1章 簡介

第2章 市場定義

第3章 推動市場的要素

第4章 阻礙市場的要素

第5章 市場機會

第6章 抗球蟲藥

  • 簡介
  • 全球市場
  • 雞的球蟲症
  • 牛的球蟲症
  • 豬的球蟲症
  • 寵物的球蟲症
  • 各藥物市場

第7章 抗球蟲藥市場的各地區分析(市場規模、預測、年複合成長率)

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美

第8章 各動物市場區隔:抗球蟲藥市場(市場規模,預測,年複合成長率)

  • 簡介
  • 反芻動物

第9章 未來的抗球蟲藥市場

第10章 競爭環境

第11章 企業簡介

  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第12章 免責聲明

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The global anticoccidial drugs market in animal health is expected to reach USD 24.33 billion by the year 2020.

Global Anticoccidial Drugs Market in Animal Health- Market Dynamics

In the veterinary antibiotic market, the market for food producing animals accounted for nearly 80% of the total market in 2011. This has increased the demand for anticoccidial drugs, largely due to the increased incidence of coccidiosis and other protozoan parasite based diseases that infect majorly food producing organisms but are not limited to them. In the poultry and cattle markets, the incidence of coccidiosis has cost millions of dollars in treatment and preventive care. Also, the trend of owning companion animals is also contributing to the increasing use of anticoccidials, as dogs, cats and occasionally even horses are prone to coccidiosis and if left untreated, it could lead to the death of the animal.

Drivers

Some of the other factors driving this market are:

Increase in global population

Increase in the per capita global consumption of meat

Increased adoption of intensive farming methods

The global anticoccidial market has been segmented on the basis of animal type (poultry, cattle, swine, and companion animals), drugs (ionophore anticoccidials, chemical derivative anticoccidials, and antibiotic anticoccidials), and by geography (North America, Europe, Asia-Pacific and Rest of the World).

The Asia-Pacific region is set to be the largest contributor in terms of total revenue in this market by the year 2020. The countries set to be major contributors in this region are China, India, Japan, and Australia. The growth in the North American and European markets is set to be stagnant due to the stagnated market and government restrictions.

Some of the key players in the market are:

Bayer Healthcare Animal Healthcare Division

Elanco (A division of Eli Lilly and Company)

Merck Animal Healthcare

Merial

Zoetis

What the Report Offers

Market definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the anticoccidial drugs market in the healthcare industry, with region specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the anticoccidial drugs market in the healthcare industry on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. Introduction

2. Market Definition

3. Market Drivers

4. Market Restraints

5. Market opportunities

6. Anticoccidial drugs

  • 6.1 Introduction
  • 6.2 Global market
  • 6.3 Coccidiosis in Poultry
    • 6.3.1 Commonly used anticoccidials in poultry
    • 6.3.2 Drug administration modes and Dosage
  • 6.4 Coccidiosis in Cattle
    • 6.4.1 Commonly used anticoccidials in cattle
    • 6.4.2 Drug administration modes and dosage
    • 6.4.3 Commonly used coccidiostats in cattle
  • 6.5 Coccidiosis in Swine
    • 6.5.1 Commonly used anticoccidials in Swine
    • 6.5.2 Drug Administration modes and dosage
  • 6.6 Coccidiosis in companion animals
    • 6.6.1 Coccidiosis in dogs
    • 6.6.2 Coccidiosis in cats
    • 6.6.3 Commonly used anticoccidials for Dogs, Dosage, and mode of administration
    • 6.6.4 Commonly used anticoccidials for cats, dosage, and modes of Administration
  • 6.7 Anticoccidials market by types of drugs
    • 6.7.1 Ionophore anticoccidials
    • 6.7.2 Chemical derivative anticoccidials
    • 6.7.3 Antibiotic anticoccidials

7. Region-wise analysis of anticoccidial market (Market size, Forecast, and CAGR)

  • 7.1. Introduction
  • 7.2 North America
  • 7.3 Europe
  • 7.4 Asia-Pacific
  • 7.5 South America

8. Segmentation by Animal Type - anticoccidial market (Market size, Forecast, and CAGR)

  • 8.1. Introduction
  • 8.2. Swine
  • 8.3 Poultry
  • 8.4 Fish
  • 8.5 Ruminant

9 The future of anticoccidial market 10 Competitive Landscape

  • 10.1 Introduction
  • 10.2 Top contenders in the market
  • 10.3 top contenders in the market

11 Company Profiles

  • 11.1 Zoetis
  • 11.2 Elanco (A division of Eli Lilly and Company)
  • 11.3 Merial
  • 11.4 Bayer Healthcare Animal Healthcare division
  • 11.5 Merck Animal Healthcare
  • 11.6 Boehringer Ingelheim Animal Health
  • 11.7 Virbac
  • 11.8 Ceva Animal Healthcare

12 Disclaimer

Back to Top